Thibald Chalas
YOU?
Author Swipe
View article: Association between drug-related cutaneous adverse events and survival outcomes in patients treated with enfortumab vedotin
Association between drug-related cutaneous adverse events and survival outcomes in patients treated with enfortumab vedotin Open
These results support that patients experiencing any-grade cutaneous toxicity (skin rash) had a prolonged PFS. With the recent expansion of combined treatment using EV plus pembrolizumab in first-line in mUC patients, cutaneous toxicities …